Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Lack of KIR4.1 autoantibodies in Japanese patients with MS and NMO.
Pediatric multiple sclerosis: Escalation and emerging treatments.
Interleukins 17 and 10 in a sample of Egyptian relapsing remitting multiple sclerosis patients.
Multiple sclerosis: experimental models and reality.
[PHYSICAL EXERCISE FOR PEOPLE WITH MULTIPLE SCLEROSIS: EFFECTS, RECOMMENDATIONS AND BARRIERS].
Laquinimod arrests experimental autoimmune encephalomyelitis by activating the aryl hydrocarbon receptor.
Evaluation of species difference in peripheral lymphocyte reduction effect by CS-0777, a sphingosine 1-phosphate receptor modulator, based on a pharmacokinetic/pharmacodynamic model analysis.
Action of treosulfan in myelin-oligodendrocyte-glycoprotein-induced experimental autoimmune encephalomyelitis and human lymphocytes.
Reorganization of Lipid Diffusion by Myelin Basic Protein as Revealed by STED Nanoscopy.
Multislice T1 -prepared 2D single-shot EPI: analysis of a clinical T1 mapping method unbiased by B0 or B1 inhomogeneity.
If they are OK, we are OK: the experience of partners living with neuromyelitis optica.
Network Modeling of Crohn's Disease Incidence.
Spatial analysis of global prevalence of multiple sclerosis suggests need for an updated prevalence scale.
Thymectomy and azathioprine have no effect on the phenotype of CD4 T lymphocyte subsets in myasthenia gravis.
A Bodybuilder With Weak Hands and Feet: Corticosteroid-Responsive Pure Motor Chronic Inflammatory Demyelinating Polyradiculoneuropathy Following Anabolic Steroid Use.
Glycyrrhizic acid prevents astrocyte death by neuromyelitis optica-specific IgG via inhibition of C1q binding.
Design of Polyelectrolyte Multilayers to Promote Immunological Tolerance.
Erratum to: IFN-gamma signaling in the central nervous system controls the course of experimental autoimmune encephalomyelitis independently of the localization and composition of inflammatory foci.
Walking fatigability in multiple sclerosis: A comparison between the 2- and the 6-minute walk test and an evaluation of associated factors.
Comparison of Personal Resources in Patients Who Differently Estimate the Impact of Multiple Sclerosis.
Influenza vaccination increases anti-JC virus antibody levels during treatment with Natalizumab: Case report.
Changes in Multidigit Synergies and Their Feed-Forward Adjustments in Multiple Sclerosis.
The obesity-related pathology and Th17 cells.
An update on the evidence base for peginterferon β1a in the treatment of relapsing-remitting multiple sclerosis.
Bioinformatics evaluation of the possibility of heat shock proteins as autoantigens in multiple sclerosis based on molecular mimicry hypothesis.

Pages